Rectal, Esophageal, and Pancreatic Cancer Stacked Testing

November 2021 Vol 12, No 11
Amanda Wright, RN, BSN
OSF Saint James Medical Center
Peoria, IL
Kathy Comella, RN, BSN
OSF Saint James Medical Center
Peoria, IL

Background: Our organization had the opportunity to reduce the time of discovery of suspicious mass to surgeon consultation for patients with rectal, esophageal, and pancreatic cancer.

Cancer patients undergo many tests that need to be completed for development of a treatment plan. Standard testing is often fragmented or incomplete, requires multiple preps, and can take 3 to 4 weeks. This leaves the patient with unanswered questions, valuable time wasted, poor patient satisfaction, increased anxiety levels, time off work, and another office visit to the surgeon. Our organization serves many rural areas, and patients travel from as far as 110 miles away. The ineffective testing process was highly frustrating to the patients, families, and the cancer care team.

Objective: To create a streamlined testing process in which newly diagnosed cancer patients can get all staging workup completed in 1 day prior to their consultation with the surgeon. This process improvement would expedite development of a treatment plan, ultimately decrease the time from diagnosis to the beginning of cancer treatment, and improve patient outcomes.

Methods: A Rapid Improvement Model project, led by nurse navigators, was used to create a streamlined process in which patient staging workup is completed in 1 day and discussion at our gastrointestinal (GI) cancer conference and a surgeon consultation occur within a 1-week period. With the new process, the patient is scheduled for stacked testing once a mass is discovered upon esophagogastroduodenoscopy (EGD), colonoscopy, or imaging. Stacked testing is done on Monday and Tuesday mornings, discussion at the GI cancer conference with the cancer team on Wednesday, and the patient is seen by the surgeon in the office. At that surgeon consultation, the surgeon has reviewed the case in cancer conference and can discuss with the patient and their family the cancer staging and treatment plan.

Results: This innovative and efficient process has shown a decrease in the length of time in the development of a treatment plan. For rectal cancer patients, from mass to surgeon consultation, the time decreased from 22 to 14 days. For esophageal cancer patients, from EGD to surgeon consultation, the time decreased from 25.35 to 14 days. For pancreatic cancer patients, from mass on imag-ing to surgeon consultation, the time decreased from 39.37 to 12 days. The process ensures that testing is completed per National Comprehensive Cancer Network guidelines, providing quality cancer care.

Conclusions: This innovative process has shown a decrease in the length of time in the development of a treatment plan and has improved patient and provider satisfaction and ultimately patient outcomes.

Related Articles
Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey
November 2022 Vol 13, No 11
To examine how SEs impacting QOL in pts with ABC are perceived.
Intracranial Activity of Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non–Small-Cell Lung Cancer (NSCLC) Enrolled in VISION
November 2022 Vol 13, No 11
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor
November 2022 Vol 13, No 11
MF is a rare bone marrow cancer characterized by fibrosis, abnormal blood cell production, and dysregulated JAK/STAT signaling.1,2
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State